FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice

FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice

Chronic kidney disease (CKD) is a worldwide health problem. Serum levels of FGF23, a phosphaturic hormone, increase at the earliest stages of CKD, and have been found to be independently associated with the mortality and morbidity of CKD patients. The purpose of this study was to evaluate whether FG...

Full description

Bibliographic Details
Main Authors: Sun, Ningyuan, Guo, Yuchen, Liu, Weiqing, Densmore, Michael, Shalhoub, Victoria, Erben, Reinhold G., Ye, Ling, Lanske, Beate, Yuan, Quan
Format: Online
Language:English
Published: Nature Publishing Group 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322353/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322353/

Similar Items